- Briefing Your roundup of Asian tech and startup news that matter
Aditya Hadi Pratama · · 1 min readSingaporean cancer diagnostics startup secures $77m in series C funding
Mirxes, the Singapore-based biotechnology startup focused on cancer detection, announced it has raised US$77 million in its latest round.
More funding details
- Lead investor: CR-CP Life Science Fund, a joint venture set up by Hong Kong conglomerate China Resources Group and Thai conglomerate Charoen Pokphand Group
- Other investors: Global healthcare investment firm Rock Springs Capital, EDBI, CCBI, and Keytone Ventures
- Stage: Series C
More company updates
- The round pushes Mirxes’ total amount raised from investors to US$120 million to date. The company says that it is the largest funding raised by a Singapore-headquartered cancer diagnostics firm.
- The company is chasing after the holy grail of medicine: cancer prevention.
- It plans to use the fresh funds to develop and commercialize its multi-cancer early detection tests and accelerate regulatory approval and adoption of its detection test for gastric cancer.
- The company will also be doubling its talent pool to 400 staff in the next two years, mostly for its research and development, data science, and commercial teams.
- Singapore may have no shortage of technological infrastructure, talent, or governmental support, but a series of hurdles have hindered the widespread adoption of medtech products like Mirxes’.
-
Mirxes currently collaborates with academic and clinical institutions in Singapore, the United States, China, Italy, and Japan to conduct large-scale clinical studies on lung, colorectal, liver, breast, and pancreatic cancers.
For more coverage of the company, head here. You can also click on the link below to view key details about the company as well as its funding history.
Editing by Collin Furtado and September Grace Mahino
(And yes, we’re serious about ethics and transparency. More information here.)
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.
